Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas

Archive ouverte

Surun, Aurore | Varlet, Pascale | Brugières, Laurence | Lacour, Brigitte | Faure-Conter, Cécile | Leblond, Pierre | Bertozzi-Salomon, Anne-Isabelle | Berger, Claire | André, Nicolas | Sariban, Eric | Raimbault, Sandra | Prieur, Fabienne | Desseigne, Françoise | Zattara, Hélène | Guimbaud, Rosine | Polivka, Marc | Delisle, Marie-Bernadette | Vasiljevic, Alexandre | Maurage, Claude-Alain | Figarella-Branger, Dominique | Coulet, Florence | Guerrini-Rousseau, Léa | Alapetite, Claire | Dufour, Christelle | Colas, Chrystelle | Doz, François | Bourdeaut, Franck

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Abstract Background Medulloblastomas may occur in a predisposition context, including familial adenomatosis polyposis. Medulloblastomas related to a germline pathogenic variant of adenomatous polyposis coli (APC) remain rare and poorly described. Their similarities with sporadic WNT medulloblastomas still require description. Methods We performed a multicentric retrospective review of 12 patients treated between 1988 and 2018 for medulloblastoma with an identified or highly suspected (personal or familial history) APC germline pathogenic variant. We report personal and familial history APC gene pathogenic variants whenever available: clinical and histologic characteristics of the medulloblastoma, treatments, and long-term outcome, including second tumor and late sequelae. Results Medulloblastomas associated with APC pathogenic variants are mainly classic (11/11 patients, 1 not available), nonmetastatic (10/12 patients) medulloblastomas, with nuclear immunoreactivity for ß-catenin (9/9 tested cases). Ten of 11 assessable patients are disease free with a median follow-up of 10.7 years (range, 1–28 y). Secondary tumors included desmoid tumors in 7 patients (9 tumors), 1 thyroid carcinoma, 2 pilomatricomas, 1 osteoma, 1 vertebral hemangioma, and 1 malignant triton in the radiation field, which caused the only cancer-related death in our series. Conclusions Medulloblastomas associated with an APC pathogenic variant have an overall favorable outcome, even for metastatic tumors. Yet, long-term survival is clouded by second tumor occurrence; treatment may play some role in some of these second malignancies. Our findings raise the question of applying a de-escalation therapeutic protocol to treat patients with APC germline pathogenic variants given the excellent outcome, and reduced intensity of craniospinal irradiation may be further evaluated.

Consulter en ligne

Suggestions

Du même auteur

Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas

Archive ouverte | Surun, Aurore | CCSD

International audience. Medulloblastomas may occur in a predisposition context, including familial adenomatosis polyposis. Medulloblastomas related to a germline pathogenic variant of adenomatous polyposis coli (APC...

Nanopore Sequencing as a Cutting-Edge Technology for Medulloblastoma Classification

Archive ouverte | Filser, Mathilde | CCSD

International audience. Background: Medulloblastoma (MB) is one of the most prevalent embryonal malignant brain tumors. Current classification organizes these tumors into four molecular subgroups (WNT, SHH, Group 3,...

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

Chargement des enrichissements...